Research advancements in the field of neuroscience play a key role in the scientific and technological progress of the modern medical field. No one knows this better than Dr. Konrad Talbot, who currently works as a Research Assistant Professor in Neurobiology specializing in Molecular Neuropathology at the University of Pennsylvania.

Dr. Talbot received his Ph.D. in behavioral neuroscience from UCLA in 1989, and went on to teach as an assistant professor in psychology first at Mount St. Mary’s College in California (1990-1995) and then St. Olaf College in Minnesota (1995-1997). After introducing a seminar on biological psychiatry and initiating student-assisted research on Alzheimer Disease, he began pursuing full-time clinical research. This led him to become a postdoctoral fellow in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania (1997-2001). Finally, in 2001, Dr. Talbot accepted an invitation from Dr. Steven Arnold in 2001 to become a senior research investigator in the Department of Psychiatry at the University of Pennsylvania, where he works today. Since his faculty appointment in January of 2008, the focus of Dr. Talbot’s research has been insulin signaling abnormalities in AD and aspects of synaptic pathology in schizophrenia.

While trained broadly in behavioral neuroscience, Dr. Talbot’s particular expertise lies in neuro-anatomical and neuro-chemical analysis of the mammalian central nervous system. He is a long-term consultant on mouse and rat brain atlases and serves when needed as a dissector for the brain autopsy team of the Center for Neurodegenerative Research at the University of Pennsylvania. His expertise has been called upon as a reviewer for journals such as Biological Psychiatry, Diabetes, Molecular Psychiatry, Schizophrenia Research and as chairman of symposia at the American College of Neuropsychopharmacology and the Society for Neuroscience.

Through Dr. Talbot’s investigation of Alzheimer Disease and Schizophrenia he has established collaborations with investigators across the U.S., Britain, and Singapore, and organized a symposium at the Society for Neuroscience in 2004. He also wrote the first comprehensive review on dysbindin-1 and its protein family for the Handbook of Neurochemistry and Molecular Neurobiology (3rd ed., in press, 2008).

Dr. Talbot stays up to date on advances in the industry by reading his favorite publication, Neuron, and is affiliated with the Society for Neuroscience. Among many accolades he received the Shepard Ivory Franz Teaching Award from UCLA and the T.L.L. Temple Foundation Discovery Award from the Alzheimer Disease Association.

A well-rounded community member, his enjoys creative writing, cooking, opera history, and photography. Dr. Konrad Talbot can be found in the Madison Who’s Who Directory and looks forward to networking with you.

http://www.med.upenn.edu/cnb/faculty_talbot.html